NFKB1 and endothelial dysfunction: In summary, our study provided strong evidence suggesting that type 2 diabetes impairs HDL-mediated eNOS activation and HDL-mediated attenuation of NFκB signaling in endothelial cells and that this HDL dysfunction may be associated with in vivo endothelial dysfunction.